神经保护市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPMD00002291
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Neuroprotection Market Scope and Size by 2031

Buy Now

神经保护是能够影响神经退行性疾病的病因或发病机制的参与。它们延缓神经退行性疾病的发生或发展。神经保护产品是保护大脑神经元免受恶化和损伤的药物。这些产品用于治疗多种中枢神经系统并发症,例如阿尔茨海默病、帕金森病和创伤性脑损伤等。临床管道中的神经保护药物包括小分子药物、基因和细胞疗法、治疗性单克隆抗体和其他药物

由于驱动力的推动,神经保护市场预计在预测几年内将以显着的速度增长这些因素包括制药和生物技术行业药物开发的不断增长、患者群体的增加、中枢神经系统疾病发病率的上升、对神经退行性疾病更具针对性的药物治疗需求的增加以及有利的政府法规。发展中经济体不断增加的医疗基础设施和日益增强的经济稳定性可能会为神经保护市场提供更多机会。

“2031年全球神经保护市场分析”是对医疗器械行业的专业和深入研究,重点关注全球市场趋势。该报告旨在概述全球神经保护市场,并按产品、应用和地理位置进行详细的市场细分。预计全球神经保护市场在预测期内将出现高速增长。该报告提供了主要市场参与者的市场状况的关键统计数据,并提供了神经保护市场的主要趋势和机会。

全球神经保护市场根据产品和应用进行细分。根据产品,神经保护市场已细分为自由基捕获剂(抗氧化剂)、细胞凋亡抑制剂、抗炎剂、谷氨酸拮抗剂(抗兴奋性毒性剂)、金属离子螯合剂等。应用部分分为治疗和预防。

该报告提供了该行业的详细概述,包括定性和定量信息。它根据产品、应用和地理位置提供了全球神经保护市场的概述和预测。它还提供了五个主要地区的整体神经保护市场的市场规模和到 2031 年的预测,即:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美和非洲中美洲。每个地区的市场随后按各自的国家和细分市场进行细分。该报告涵盖了对全球 13 个国家的分析和预测,以及该地区当前的趋势和机遇。

北美预计将在未来几年占据神经保护市场的最大份额,原因是各种市场参与者在该地区开展业务等因素。欧洲地区预计将成为神经保护的第二大市场。预计亚太地区将成为增长最快的市场,因为这些国家的神经系统疾病数量不断增加,重要品牌之间竞争加剧导致定价压力的影响,仿制药的兴起以及能够提供服务的区域参与者数量不断增加以更低的价格提供产品。

报告从需求和供给两个方面分析了影响市场的因素,并进一步评估了预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。该报告还为所有五个地区提供了详尽的 PEST 分析,即:北美、欧洲、亚太地区、中东和非洲以及南美洲和南美洲中美洲在评估了影响这些地区市场的政治、经济、社会和技术因素后。

该报告还包括主要神经保护市场制造公司的概况及其 SWOT 分析和市场策略。此外,报告重点关注行业领先企业,提供公司简介、提供的产品和服务、过去三年的财务信息、过去五年的主要发展等信息。影响市场的一些主要参与者包括礼来公司、艾尔建公司、雷迪博士实验室有限公司、梯瓦制药工业有限公司、第一三共公司、诺华公司、霍夫曼-拉罗氏公司、阿斯利康公司、百健公司 (Biogen Inc.)、星形细胞制药公司 (Astratory Pharmaceuticals, Inc.) 和其他知名企业。

Neuroprotection Market Report Scope

Report Attribute Details
Market size in US$ XX million
Market Size by US$ XX Million
Global CAGR XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 产品
  • 自由基捕获剂
By 应用
  • 治疗和预防
By 地理
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太地区其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Eli Lilly and Company
  • Allergan plc
  • Dr Reddy s Laboratories Ltd
  • Teva Pharmaceutical Industries Ltd
  • Daiichi Sankyo Company
  • Novartis AG
  • F Hoffmann La Roche AG
  • AstraZeneca plc
  • Biogen Inc
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Eli Lilly and Company
    2. Allergan plc
    3. Dr. Reddy’s Laboratories Ltd.
    4. Teva Pharmaceutical Industries Ltd.
    5. Daiichi Sankyo Company
    6. Novartis AG
    7. F. Hoffmann-La Roche AG
    8. AstraZeneca plc
    9. Biogen Inc.
    10. Astrocyte Pharmaceuticals, Inc.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Medical Device : READ MORE..